Most Americans use social media, making it a crucial tool in oncology, where new findings, biomarkers, treatments, and trials are presented.

Provisions in the IRA intend to lower drug costs, yet unintended consequences to this goal will likely cost far more than the money saved.

After the COVID-19 pandemic, cancer clinical trials adopted a more patient-centric approach where trials work better for participants.

A CMO is responsible for compound development success, so building awareness proactively and compliantly is critical for clinical trials.

Clinical trial failures are common and costly, yet they can teach us important lessons.

Clinical trials held in the UK have seen patient enrollment and trial numbers drop. Flexibility & creativity are needed to overcome issues.

The patient voice is vital to understanding how to guide and build the best possible tools to treat people with cancer effectively.

Social media is an affordable, accessible, and rapid means by which people with cancer can gain awareness about cancer clinical trials.